Temprian Oncology Inc.
PrivateLast Round
Seed
Aug 1, 2024
Total Funding Raised
$575,000
Company Overview
Temprian Oncology Inc. operates in Healthcare & Life Sciences and is based in Oak Park, Illinois. Its latest recorded funding round was a Seed round in August 2024.
Temprian Oncology Inc. is a biotechnology company developing highly selective nanoparticle-based supercarriers for the treatment of advanced melanoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Temprian Oncology Inc. Comparables
Compare Temprian Oncology Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saros Therapeutics | 79% | |
| Flashpoint Therapeutics | 77% | |
| NanoVax Therapeutics | 74% |
For institutional investors. Book with your work email.
Temprian Oncology Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2024 | ||||
| Grant | Dec 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Temprian Oncology Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2Flo Ventures | Seed |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors grew 436% MoM, from 122 to 654.
- Aug 1, 2024
$300K round from National Science Foundation
For institutional investors. Book with your work email.
Temprian Oncology Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Temprian Oncology Inc.'s valuation, stock price, and market status.
Is Temprian Oncology Inc. a public or private company?
Temprian Oncology Inc. is a private company.
What is the current stock price of Temprian Oncology Inc.?
Temprian Oncology Inc. is a private company, so its shares have no public market price. Caplight tracks Temprian Oncology Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Temprian Oncology Inc. worth (valuation)?
Valuation information for Temprian Oncology Inc. is not publicly available.
Can I buy Temprian Oncology Inc. stock?
Temprian Oncology Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Temprian Oncology Inc.'s last funding round?
Temprian Oncology Inc.'s most recent funding round was Seed on August 1, 2024.
Who are the main investors in Temprian Oncology Inc.?
Key investors in Temprian Oncology Inc. include National Science Foundation.
Will Temprian Oncology Inc. IPO soon?
No public IPO plans have been announced for Temprian Oncology Inc..
How can I track Temprian Oncology Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Temprian Oncology Inc.'s shares on secondary markets.